Synopsis
0
CEP/COS
0
JDMF
0
EU WC
0
VMF
DRUG PRODUCT COMPOSITIONS
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
API SUPPLIERS
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]
USDMF
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]NDC API
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Listed Suppliers
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]API Reference Price
API Imports and Exports
Drugs in Development
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]FDF Dossiers
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]FDA Orange Book
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Europe
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Canada
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Australia
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Related Excipient Companies
Actylis
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Parenteral
Film Formers & Plasticizers
Coating Systems & Additives
Topical
Controlled & Modified Release
Digital Content
NEWS #PharmaBuzz
Global Sales Information
Market Place
REF. STANDARDS & IMPURITIES
ABOUT THIS PAGE
A Idarubicin Hydrochloride manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Idarubicin Hydrochloride, including repackagers and relabelers. The FDA regulates Idarubicin Hydrochloride manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Idarubicin Hydrochloride API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of Idarubicin Hydrochloride manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A Idarubicin Hydrochloride supplier is an individual or a company that provides Idarubicin Hydrochloride active pharmaceutical ingredient (API) or Idarubicin Hydrochloride finished formulations upon request. The Idarubicin Hydrochloride suppliers may include Idarubicin Hydrochloride API manufacturers, exporters, distributors and traders.
click here to find a list of Idarubicin Hydrochloride suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
A Idarubicin Hydrochloride DMF (Drug Master File) is a document detailing the whole manufacturing process of Idarubicin Hydrochloride active pharmaceutical ingredient (API) in detail. Different forms of Idarubicin Hydrochloride DMFs exist exist since differing nations have different regulations, such as Idarubicin Hydrochloride USDMF, ASMF (EDMF), JDMF, CDMF, etc.
A Idarubicin Hydrochloride DMF submitted to regulatory agencies in the US is known as a USDMF. Idarubicin Hydrochloride USDMF includes data on Idarubicin Hydrochloride's chemical properties, information on the facilities and procedures used, and details about packaging and storage. The Idarubicin Hydrochloride USDMF is kept confidential to protect the manufacturer’s intellectual property.
click here to find a list of Idarubicin Hydrochloride suppliers with USDMF on PharmaCompass.
In Korea, the Ministry of Food and Drug Safety (MFDS) is in charge of regulating pharmaceutical products and services.
Pharmaceutical companies submit a Idarubicin Hydrochloride Drug Master File in Korea (Idarubicin Hydrochloride KDMF) to the MFDS, which includes comprehensive information about the production, processing, facilities, materials, packaging, and testing of Idarubicin Hydrochloride. The MFDS reviews the Idarubicin Hydrochloride KDMF as part of the drug registration process and uses the information provided in the Idarubicin Hydrochloride KDMF to evaluate the safety and efficacy of the drug.
After submitting a Idarubicin Hydrochloride KDMF to the MFDS, the registered manufacturer can provide importers or distributors with the registration number without revealing confidential information to Korean business partners. Applicants seeking to register their Idarubicin Hydrochloride API can apply through the Korea Drug Master File (KDMF).
click here to find a list of Idarubicin Hydrochloride suppliers with KDMF on PharmaCompass.
National Drug Code is a comprehensive database maintained by the FDA that contains information on all drugs marketed in the US. This directory includes information about finished drug products, unfinished drug products, and compounded drug products, including those containing Idarubicin Hydrochloride as an active pharmaceutical ingredient (API).
The FDA updates the NDC directory daily. The NDC numbers for Idarubicin Hydrochloride API and other APIs are published in this directory by the FDA.
The NDC unfinished drugs database includes product listing information submitted for all unfinished drugs, such as active pharmaceutical ingredients (APIs), drugs intended for further processing and bulk drug substances for compounding.
Pharmaceutical companies that manufacture Idarubicin Hydrochloride as an active pharmaceutical ingredient (API) must furnish the FDA with an updated record of all drugs that they produce, prepare, propagate, compound, or process for commercial distribution in the US at their facilities.
The NDC directory also contains data on finished compounded human drug products that contain Idarubicin Hydrochloride and are produced by outsourcing facilities. While these outsourcing facilities are not mandated to assign a Idarubicin Hydrochloride NDC to their finished compounded human drug products, they may choose to do so.
click here to find a list of Idarubicin Hydrochloride suppliers with NDC on PharmaCompass.
Idarubicin Hydrochloride Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Idarubicin Hydrochloride GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Idarubicin Hydrochloride GMP manufacturer or Idarubicin Hydrochloride GMP API supplier for your needs.
A Idarubicin Hydrochloride CoA (Certificate of Analysis) is a formal document that attests to Idarubicin Hydrochloride's compliance with Idarubicin Hydrochloride specifications and serves as a tool for batch-level quality control.
Idarubicin Hydrochloride CoA mostly includes findings from lab analyses of a specific batch. For each Idarubicin Hydrochloride CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Idarubicin Hydrochloride may be tested according to a variety of international standards, such as European Pharmacopoeia (Idarubicin Hydrochloride EP), Idarubicin Hydrochloride JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Idarubicin Hydrochloride USP).
LOOKING FOR A SUPPLIER?
